BlackRock Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.4M Buy
32,562
+1,248
+4% +$50.7K ﹤0.01% 1692
2016
Q3
$1.29M Buy
31,314
+3,208
+11% +$134K ﹤0.01% 1681
2016
Q2
$1.12M Buy
28,106
+1,812
+7% +$65.2K ﹤0.01% 1714
2016
Q1
$886K Buy
26,294
+1,704
+7% +$53.1K ﹤0.01% 1797
2015
Q4
$833K Sell
24,590
-11,470
-32% -$359K ﹤0.01% 1805
2015
Q3
$1.07M Sell
36,060
-4,980
-12% -$156K ﹤0.01% 1641
2015
Q2
$1.13M Buy
41,040
+2,865
+8% +$76.4K ﹤0.01% 1573
2015
Q1
$962K Buy
38,175
+5,652
+17% +$134K ﹤0.01% 1583
2014
Q4
$721K Sell
32,523
-1,478
-4% -$30K ﹤0.01% 1720
2014
Q3
$690K Sell
34,001
-621
-2% -$12.4K ﹤0.01% 1710
2014
Q2
$666K Sell
34,622
-3,176
-8% -$59.2K ﹤0.01% 1797
2014
Q1
$711K Buy
37,798
+1,549
+4% +$29.9K ﹤0.01% 1790
2013
Q4
$707K Buy
36,249
+6,776
+23% +$124K ﹤0.01% 1758
2013
Q3
$485K Buy
29,473
+402
+1% +$6.45K ﹤0.01% 1928
2013
Q2
$435K Buy
+29,071
New +$426K ﹤0.01% 1927

Other funds holding IART

BlackRock Advisors's IART Position: Q4 2016 in Review

BlackRock Advisors increased its Integra LifeSciences (IART) stake by 4% in Q4 2016, buying an estimated $50.7K and bringing the position to 32,562 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

BlackRock Advisors first reported a position in IART in Q2 2013 and has held it in 15 quarters since. 224 funds tracked by Wall St. Rank hold IART as of Q4 2016.

  • BlackRock Advisors held 32,562 shares of Integra LifeSciences worth $1.4M as of Q4 2016.
  • BlackRock Advisors bought 1,248 Integra LifeSciences shares in Q4 2016, an estimated $50.7K.
  • Integra LifeSciences made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1692 holding.
  • BlackRock Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 15 quarters since.
  • 224 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.